Last reviewed · How we verify
THDB0206 Injection-Thigh — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
THDB0206 Injection-Thigh (THDB0206 Injection-Thigh) — Tonghua Dongbao Pharmaceutical Co.,Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| THDB0206 Injection-Thigh TARGET | THDB0206 Injection-Thigh | Tonghua Dongbao Pharmaceutical Co.,Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- THDB0206 Injection-Thigh CI watch — RSS
- THDB0206 Injection-Thigh CI watch — Atom
- THDB0206 Injection-Thigh CI watch — JSON
- THDB0206 Injection-Thigh alone — RSS
Cite this brief
Drug Landscape (2026). THDB0206 Injection-Thigh — Competitive Intelligence Brief. https://druglandscape.com/ci/thdb0206-injection-thigh. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing